Lv3
292 积分 2025-04-22 加入
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist
13小时前
已完结
Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials
9天前
已完结
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1
9天前
已完结
Abstract 1966: The FLT3 tyrosine kinase receptor ITD mutation controls its expression and drug resistance in acute myeloid leukemia
1个月前
已关闭
Single-Cell Lineage Tracing Uncovers Resistance Signatures and Sensitizing Strategies to FLT3 Inhibitors in Acute Myeloid Leukemia
1个月前
已完结
Single-Cell Proteomic Interrogation of FLT3-ITD Leukemia Compartment Revealsdistinct Leukemia Cell Populations Resistant to Quizartinib, Decitabine and Venetoclax
1个月前
已关闭
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Capsaicin derivatives with nitrothiophene substituents: Design, synthesis and antibacterial activity against multidrug-resistant S. aureus
3个月前
已完结
Development of Orally Bioavailable FTO Inhibitors with Potent Antileukemia Efficacy
3个月前
已完结
Discovery of Covalent and Cell‐Active ALKBH5 Inhibitors with Potent Antileukemia Effects In Vivo
3个月前
已完结
皖公网安备34019202002308
